- News & Analysis
Page 357
Cerenis closes C round at $70m
French investors back C round extension for Cerenis Therapeutics.
Oct 22, 2010Docomo calls in on Evernote
NTT Docomo's corporate venturing unit backs Evernote's $20m series C round.
Oct 20, 2010SolarEdge lights on $25m C round
In October last year, GE Energy Financial Services joined a previous consortium investing $23m in SolarEdge Technologies as its first investment in Israel.
Oct 17, 2010UCB shakes on $20m Synosia investment
UCB drugs company invests $20m and signs licensing agreement worth up to $725m with Synosia Therapeutics.
Oct 13, 2010Swisscom adds to Immatics harvest
Europe's largest venture round of the year doubles to more than $150m the amount raised by Immatics Biotechnologies since its launch.
Oct 10, 2010Symetis sniffs up venture round
Novartis and Truffle Capital part of consortium in $25.8m C round for Switzerland's Symetis.
Oct 8, 2010Nokia and Cisco find their Netmagic
Nokia Growth Partners and Cisco join mutual fund company Fidelity International in Netmagic Solutions' $12.5m latest round.
Oct 7, 2010Microsoft re-emerges as venture investor
Software group Microsoft has reemerged as a corporate venturing investor by joining AppNexus' latest round.
Oct 7, 2010Threatmetrix rejects initial CyberSource overtures
CyberSource's $2bn acquisition by credit card company Visa scuppers initial plans to join Threatmetrix's investor list.
Oct 6, 2010About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin